BSEResult▲ PositiveResults4 Nov 2026
Exide Industries Ltd
Please find enclosed letter w.r.t unaudited financial results for quarter and half year ended 30th September 2026.
Exide Industries Ltd reported unaudited financial results for Q2 and H1 FY27, with revenue growth of 18.9% and PAT growth of 46.7%. The company commissioned 6 GWh of Lithium-ion Cell Gigafactory.
NSEPress Release▲ PositiveResults4 Nov 2026
Biocon Limited
Press Release
Biocon Limited has announced its consolidated financial results for the quarter and half-year ended September 30, 2026, with a 2% YoY increase in consolidated operating revenue to Rs 4,389 crore and a 5% YoY increase in biopharma revenue to Rs 3,583 crore.
BSECompany Update▲ PositiveResults4 Nov 2026
Biocon Ltd
Press Release
Biocon Ltd announced its consolidated financial results for the quarter and half-year ended September 30, 2026, with a 2% YoY increase in consolidated operating revenue to Rs 4,389 crore and a 5% YoY increase in biopharma revenue to Rs 3,583 crore.
NSEPress Release▲ PositiveResults4 Nov 2026
Keystone Realtors Limited
Press Release
Keystone Realtors Limited has announced its unaudited financial results for Q2FY27, with highest ever quarterly pre-sales of INR 14.23 billion, up 84% YoY, and highest ever quarterly PAT of INR 1.01 billion.
BSECompany Update▲ PositiveResults4 Nov 2026
CL Educate Ltd
Intimation of Schedule of Analysts and Investors Earnings Call pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
CL Educate Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a 13.2% increase in EBITDA and a 289 bps expansion in EBITDA margin.
NSEOutcome of Board Meeting▲ PositiveResults4 Nov 2026
Exide Industries Limited
Outcome of Board Meeting
Exide Industries Limited has announced its Q2 FY27 financial results, with revenue growth of 18.9% and PAT growth of 46.7%. The company has also commissioned 6 GWh of Lithium-ion Cell Gigafactory.
BSEBoard Meeting▲ PositiveResults4 Nov 2026
Exide Industries Ltd
Please find enclosed letter w.r.t outcome of Board Meeting for the quarter and half year ended 30th September 2026.
Exide Industries Ltd reported Q2 FY27 revenue growth of 20.3% YoY to Rs. 5,026 Crore, with PAT growth of 75.1% YoY to Rs. 386 Crore. The company commissioned 6 GWh of Lithium-ion Cell Gigafactory.
BSECompany Update▲ PositiveResults4 Nov 2026
Keystone Realtors Ltd
Press Release for the unaudited financial results (consolidated and standalone) for the quarter and half year ended September 30, 2026
Keystone Realtors Ltd reported its unaudited financial results for Q2FY27, with highest ever quarterly pre-sales of INR 14.23 billion, up 84% YoY, and highest ever quarterly PAT of INR 1.01 billion. The company achieved 41% of its full-year FY27 pre-sales guidance within the first half of FY27.
NSEPress Release▲ PositiveResults4 Nov 2026
Sundaram Clayton Limited
Press Release
Sundaram Clayton Limited has reported strong performance in Q2 FY27 with a 37% growth in standalone revenue and a 96% rise in PAT.
BSECompany Update▲ PositiveResults4 Nov 2026
Sundaram-Clayton Ltd
Announcement under Regulation 30 (LODR) - Press Release
Sundaram-Clayton Ltd reported strong Q2 FY27 performance with 37% revenue growth and 96% PAT rise, driven by broad-based customer growth and robust export demand.
BSECompany Update▲ PositiveResults4 Nov 2026
Ester Industries Ltd
Press Release on Un-Audited Financial Results of the Company for the quarter and half year ended 30th September 2026.
Ester Industries Ltd reported strong Q2FY27 performance with Revenue growth of 25.7%, EBITDA up by 160.0% Y-o-Y, and Margins improve by approximately 510 bps. The company's consolidated Total Income increased 25.7% Y-o-Y to ₹449.0 crores, while EBITDA more than doubled, rising 160% Y-o-Y to ₹45.1 crores.
BSECompany Update▲ PositiveResults4 Nov 2026
Multi Commodity Exchange of India Ltd
Investor Presentation for the quarter and half year ended September 30, 2026.
Multi Commodity Exchange of India Ltd has released its Q2 FY27 investor presentation, showcasing steady growth momentum with total income, EBITDA, and profit after tax increasing by 98.6%, 121.3%, and 116.4% YoY respectively.
BSECompany Update▲ PositiveResults4 Nov 2026
GlaxoSmithKline Pharmaceuticals Ltd
Analyst meet Presentation
GlaxoSmithKline Pharmaceuticals Ltd has announced its Q2 FY27 financial results, with revenue growth of 21%, EBITDA margin of 34%, and PAT margin of 33%. The company's key brands have maintained their competitive performance in the market.
NSEPress Release▲ PositiveResults4 Nov 2026
Ester Industries Limited
Press Release
Ester Industries Limited has reported strong Q2FY27 performance with Revenue growth of 25.7%, EBITDA up by 160.0% Y-o-Y, and Margins improve by approximately 510 bps. The company has also announced its unaudited financial results for the half year ended 30th September 2026.
NSEInvestor Presentation▲ PositiveResults4 Nov 2026
GlaxoSmithKline Pharmaceuticals Limited
Investor Presentation
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Investor Presentation, highlighting its growth momentum, key focus areas, and financial highlights for Q2 FY27.
BSECompany Update▲ PositiveResults4 Nov 2026
Ester Industries Ltd
Ester Industries Limited has informed the Exchange about Investor Presentation.
Ester Industries Ltd has announced its un-audited financial results for Q2 and H1 FY27, showing a 25.7% YoY increase in consolidated income to ₹449 Cr and a 160% YoY increase in EBITDA to ₹45.1 Cr. The company has also provided an update on its ELITe project, with various aspects progressing well and acquisition of land expected to be completed by Q4FY27.
NSEInvestor Presentation▲ PositiveResults4 Nov 2026
Ester Industries Limited
Investor Presentation
Ester Industries Limited has informed the Exchange about Investor Presentation on Un-Audited Financial Results for the quarter and half year ended on 30th September 2026, showing a 25.7% YoY increase in consolidated income to ₹449 Cr in Q2FY27 and a 26.5% YoY growth to ₹891 crore in H1FY27, driven by strong operating performance in the Polyester Films business.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults4 Nov 2026
Motherson Sumi Wiring India Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Motherson Sumi Wiring India Limited has announced its Q2 FY'27 results, with revenue growing 47% year-on-year and 19% sequentially, and EBITDA increasing 34% year-on-year and 45% sequentially.
BSECompany Update▲ PositiveResults4 Nov 2026
Saregama India Ltd
Investor Presentation - Q2 FY 2026-27
Saregama India Ltd reported Q2 FY 2026-27 financial results with 37% YoY revenue growth, 39% YoY EBITDA growth, and 43% YoY PBT growth. Music revenue grew 35% YoY, while live events revenue grew 101% YoY.
BSECompany Update▲ PositiveResults4 Nov 2026
Motherson Sumi Wiring India Ltd
Transcript of the Investor Call
Motherson Sumi Wiring India Ltd reported a 47% year-on-year and 19% sequential revenue growth in Q2 FY'27, driven by higher customer volume, new program launches, and contributions from Greenfield plants. EBITDA increased 34% year-on-year and 45% sequentially, while profit after tax registered growth of 35% and 54% respectively.